摘要
BACKGROUND AND OBJECTIVE Patients with acute ischemic stroke related to atrial fibrillation （a-fib） are at a high risk of re-current stroke and intraeranial hemorrhage. This study compared the efficacy and safety of a non-vitamin K antagonist oral anticoagulant（NOAC） , rivaroxaban, with dose adjusted warfarin among patients with mild a-fib related, acute, ischemic stroke.
出处
《中华物理医学与康复杂志》
CAS
CSCD
北大核心
2017年第11期878-878,共1页
Chinese Journal of Physical Medicine and Rehabilitation
